title: [Effects of subcutaneous administration of pentagastrin and duodenal alkalinization on plasma group I pepsinogen (PGI-p) in man].
authors.forename: S
authors.initials: S
authors.lastname: Pustorino
authors.forename: S
authors.initials: S
authors.lastname: Turiano
authors.forename: G
authors.initials: G
authors.lastname: Luzza
authors.forename: M L
authors.initials: ML
authors.lastname: Catania
authors.forename: D
authors.initials: D
authors.lastname: Migliorato
authors.forename: L
authors.initials: L
authors.lastname: Familiari
authors.forename: T
authors.initials: T
authors.lastname: Cilluffo
authors.forename: O
authors.initials: O
authors.lastname: Ferraù
mesh_terms: D000328:Adult; D000368:Aged; D001639:Bicarbonates / Q000008:administration & dosage*; D004386:Duodenum / Q000378:metabolism*; D005260:Female; D006801:Humans; D007279:Injections, Subcutaneous; D008297:Male; D008875:Middle Aged; D010418:Pentagastrin / Q000008:administration & dosage*; D010435:Pepsinogens / Q000097:blood*; D010958:Plasminogen / Q000097:blood*; D012964:Sodium / Q000008:administration & dosage*; D017693:Sodium Bicarbonate
chemical_list: D001639:Bicarbonates; D010435:Pepsinogens; D017693:Sodium Bicarbonate; D010958:Plasminogen; D012964:Sodium; D010418:Pentagastrin
vernacular_title: Effetti della somministrazione sottocutanea di pentagastrina e dell'alcalinizzazione duodenale sul pepsinogeno plasmatico del gruppo I (PGI-p) nell'uomo.